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Abstract
The two main problems in the daily clinical practice of EEG are i) its under-use
dedicated mainly to epilepsy and ii) subjectivity in de visu analysis. However, both
problems can be overcome by using numerical tools in clinical practice that broaden
the scope and introduce real objectivity to bioelectrical measurements. We have
developed a method for quantitative EEG (qEEG) for daily use based on the
homeostatic foundation of EEG. This method is robust, easy, and not time consum-
ing and is arranged in two branches: the analysis of the spectral composition in each
channel and synchronization. Notably, channels are arranged in differential mode.
Since 2016, we have used this method for more than 4100 EEGs from scalp record-
ings in outpatients, epilepsy evaluation, and evaluation and monitoring in the
intensive care unit (ICU). We have been able to identify numerical properties that
are not visually evident in several pathologies, including COVID-19 in patients
suffering encephalopathy, and have performed diagnosis in ICU patients and dif-
ferentiation between epileptic and non-epileptic spells or minimum cognitive states.
The use of numerical variables across successive recordings in the same patient has
proven to be of great utility. We propose that qEEG use should be expanded
globally for daily clinical practice.
Keywords: encephalopathy, epilepsy, fast Fourier transform, numerical methods,
psychogenic non-epileptic seizures, spectral entropy, synchronization
1. Introduction
Electroencephalography (EEG) is one of the oldest diagnostic methods currently
used in medicine. It was described one century ago by the German psychiatrist Hans
Berger [1]. Since then, its use has rapidly spread, and practically every hospital in
the world has an EEG device. However, although EEG is probably the fastest,
cheapest, and most straightforward method to obtain neurophysiological informa-
tion from the human brain in a non-invasive way [2], its use is sometimes exces-
sively restricted to the diagnosis of epilepsy, even in patients in whom the level of
consciousness should be carefully evaluated [3]. Nevertheless, it should be always
remembered that the primary function of the cerebral cortex is to exchange
information by generating bioelectrical signals, not only in epilepsy.
In addition to this excessive restriction to epilepsy, EEG is sometimes reported
as a subjective method, depending strongly on the interpreter [4–8]. There has been
an attempt to reduce inter-rater variability among interpreters by the introduction
of a consensus for EEG interpretation [9–13]. Although these consensus and
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classifications introduce some objectivity in EEG analysis, the variables are mostly
qualitative or binary (present/absent), and specificity is therefore not very high.
In the past few decades, clinicians, neuroscientists, mathematicians, physicists,
and engineers (among other experts) have sought a way to overcome these flaws to
increase the true field of EEG application and reduce subjectivity in diagnosis. Some
research has been devoted to combining EEGs and imaging techniques, mainly
magnetic resonance imaging [14–16]. Another direction has been to develop math-
ematical tools to increase the reliability and deepen the information extracted from
neurophysiological recordings. Collectively, this approach is called quantitative
EEG (qEEG [17]). A canonical formulation toolbox is not needed to define qEEG.
Instead, we can say that every EEG recording that uses any kind of post hoc
numerical method to obtain a result about frequency spectrum, synchronization,
network dynamics, or anything else of bioelectrical magnitude can be considered
qEEG. This approach has been increasing in popularity since the introduction of
digitalization in electroencephalography. As an example, in the past few decades,
the number of papers referenced in PubMed with the word “qEEG” in the title/
abstract rose from two in 1979, to 31 in 1999, and 76 in 2019 (a factor of x38!).
However, the use of qEEG in clinical practice is far from being generalized, with the
exception of ICUs where long-term monitoring (continuous EEG, cEEG) and qEEG
are slowly increasing [18–25].
The time required for a cEEG review is one of the most commonly given reasons
for the use of qEEG in the ICU and other diagnostic fields. However, we have taken
a different approach to qEEG during cEEG or standard EEG for ambulatory/hospi-
talized patients: instead of just simplifying seizure detection (another manifestation
of the excessive focus on epilepsy), our aim is to obtain a comprehensive and
efficient view of the bioelectrical brain physiology/physiopathology in the most
objective way. To do this, we have developed qEEG using classical mathematical
methods, but in a neurophysiologically and clinically oriented fashion [26].
In this chapter, we want to describe in detail the physiological basis of
qEEGs, the method implemented for its quantification, and provide some examples
of its use.
2. Physiological basis of qEEG
We have adopted the assumption that EEG is founded in a homeostatic system
to obtain the main variables of our method [26–28]. This aspect is of extraordinary
relevance because its specific application in different pathologies will lead to spe-
cific changes in the different numerical variables obtained. EEG consists of the
multivariate spatio-temporal determination of the electrical potentials generated by
the brain and recorded on the surface of the scalp. The oscillatory activity of the
EEG, in clinical practice, is divided into four bands, depending on its oscillation
frequency: delta (δ; 0–4 Hz), theta (θ; 4–8 Hz), alpha (α; 8–13 Hz), and beta (β; 13–
30 Hz). Frequencies above 30 Hz, although very important in cognitive research,
are not customarily used in clinical practice.
Briefly, the regulation of different bands is given by the following systems [29]:
• Delta. The hyperpolarization of the thalamic-cortical (TC) interstitial
pacemaker cells by the nucleus reticularis, together with a lower excitatory
effect of the ascending activating reticular system (AARS), releases the
spontaneous activity of cortical cells, oscillating at <4 Hz. This oscillation
throughout the putamen/globus pallidus inhibits the brainstem nuclei
responsible for AARS.
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• Theta. There are two theta-generating systems: i) activation of the nucleus
reticularis (activated by the AARS) and inhibiting TC neurons and ii) through
the mesolimbic system, which includes multiple afferents from the entorhinal
cortex, hippocampus, amygdala, septum and anterior cingulate cortex;
activating the intralaminar thalamic nuclei, and projecting to layer I of the
cerebral cortex.
• Alpha. TC neurons spontaneously oscillate at 6–12 Hz and regulate the
excitation of large cortical areas through thalamic-cortico-thalamic re-entry
loops. The membrane potential of these cells determines the frequency of
oscillation and is regulated by synaptic inputs from the AARS (which includes
the intralaminar nuclei of the thalamus), mainly from the brainstem and
cortical inputs. Within the cortex, this activity is propagated from some nodes
of special importance through interneuronal connections.
• Beta. Originates primarily from cortico-cortical interactions and is facilitated
by diffuse activation of the AARS and depolarization of TC cells, allowing the
free transfer of information from the sensory systems through the thalamus to
the cerebral cortex.
This complex neuroanatomical homeostatic system is probably genetically
determined and regulates basal levels of local synchronization, global interactions
between different regions, spectral composition, and periodic signal space sampling
[30–33].
One of the main limits in our approach is to maintain a close relationship between
numerical magnitude variation and the underlying anatomo-functional system. For
example, an increase in cortical activity (e.g., a seizure) must always be associated
with an increase in β and probably α bands. Obviously, it does not preclude an
increase in slower bands, but rising activity in faster bands is mandatory [26].
3. Quantified EEG
There are two branches of analysis: power spectra and synchronization. For both
of them, dynamic (i.e., varying along the time) and mean measurements (i.e., mean
spectra or mean graph of synchronization) are obtained. The process is summarized
in Figure 1.
The process used for qEEG followed these steps:
Different length raw records are exported from the EEG device (EEG32,
NeuroWorks, XLTEK®, Oakville, ON, Canada) to an ASCII file. Usually, artifacts
are excluded by the export of several artifact-free chunks, which are later combined
for analysis. We have shown that this process does not changes the main properties
analyzed (see below). This process (exportation to an ASCII file) would probably be
different for other EEG suppliers, but we have not assessed this possibility. We have
computed the export time (texport) as a function of the ASCII file size (S) and
obtained a linear expression by means of least-square fitting (r = 0.9947):
texport sð Þ ¼ 0:43S MBð Þ þ 4:13 (1)
Although the raw recordings were digitized at 512 or 1024 Hz, we down-sampled
to 128 or 256 Hz.
Exported files are digitally are filtered by a sixth-order Butterworth digital filter
between 0.5 and 30 Hz.
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A differential EEG montage is then reconstructed. Topographic placement of
channels is defined on the scalp as the midpoint between the electrode pairs defin-
ing the channel; e.g., the Fp1–F3 channel would be placed at the midpoint of the
geodesic between the Fp1 and F3 electrodes.
All recording can be divided into different lengths of moving windows (1–5 s
each) with different overlaps (between 0 to 50%, but usually 10%). The total length
used during the fast Fourier transform (FFT) is directly related to frequency preci-
sion in the power spectrum (PS). Overlap is used to minimize the border effect
produced by windowing [35].
For each window (n) and frequency (k), we computed the fast Fourier trans-
form (FFT) of the voltage (Vm nð Þ) obtained from each channel (m) to obtain the
power spectrum (Smn,k, in μV







Nkn;m ¼ Fp1, F3, … (2)





pk log 2pk (3)
Figure 1.
Method of electroencephalogram (EEG) quantification in two branches: Power spectra (b–d) and
synchronization (e,f). (a) Raw EEG tracing. The discontinuous rectangle shows the moving window used for
analysis; (b) power spectra for each channel; (c) areas for delta, theta, alpha, and beta bands under the
spectrum are highlighted in different colors; (d) dynamics of the four bands (and entropy in the lower row) for
every lobe. Mean and SEM values for each tracing are displayed inside each graph. Red and blue lines indicate
right and left hemispheres, respectively; (e) correlation matrix for the window; (f) mean correlation computed
for all recordings [34].
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where F is the maximum frequency computed and pk is the probability density








We computed the area under the Smn,k according to the classical segmentation of
EEG bands. We used the expression:




Smn kð Þ∆k; j ¼ δ, θ, α, β (5)
The expression sup refers to the upper limit of each EEG band.
The absolute value of Pearson’s correlation coefficient (ρ) is computed for each
pair of channels (i,j) according to the expression:
ρkij ¼
PNwindow
k¼1 xi kð Þ  xið Þ
PNwindow




k¼1 xi kð Þ  xið Þ
2PNwindow
k¼1 x j kð Þ  x j
 2
q (6)
where Nwindow is the number of points included in a window (usually 128) and
xi, x j represents the mean of both channels.
The mean value of all windows is then computed, obtaining the mean correla-
tion matrix.
Areas of the same band are grouped by cerebral lobes. In the case of the left
hemisphere (shown as an example), we grouped the frontal F ¼
Fp1F3ð Þþ F3C3ð Þþ Fp1F7ð Þ
3
 




Fp1F7ð Þþ F7T3ð Þþ T3T5ð Þþ T5O1ð Þ
4
 
. Channels from the right hemi-
sphere were grouped accordingly. These areas, for both bands (j) and lobes (r),
Arj tð Þ; r ¼ F,PO,T, are plotted as time functions and compared between the
hemispheres. The same groups were used to compute SSe.
The total time of analysis (tanalysis) is obtained from this linear expression, which
was obtained from least-square fitting:
tanalysis sð Þ ¼ 0:32S MBð Þ þ 46:3 (7)
From expressions 1 and 7, for a typical 88 MB file (10 min record), we can
estimate the time spent in export + analysis as less than 2 min.
We can optionally introduce two time-markers to define different states
(e.g., pre-ictal, ictal, and post-ictal periods) in order to statistically compare the
changes.
We can optionally export the numerical results to an Excel® file (e.g.,
mean  SEM of power, synchronization; and SSe for channels, lobes, and
hemispheres). This last step is the most time-consuming (up to 3 min for a
custom-length file).
5
Necessity of Quantitative EEG for Daily Clinical Practice
DOI: http://dx.doi.org/10.5772/intechopen.94549
Numerical analysis of EEG recordings was performed with custom-made
MATLAB® software (MathWorks, Natick, MA, USA).
For power spectra as well as for synchronization, we can represent measurements
either as dynamic time-dependent variables (Figure 1d), or as the mean values,
averaged over the file (Figure 1b,f). Therefore, although complementary, informa-
tion obtained from both kinds of computations must be interpreted differently. In
other words, average measurements are only useful if the stationarity of the record is
evident (e.g., basal recordings, well-defined phases of sleep, etc.).
4. Robustness of the method
A very important aspect of any numerical method is its robustness, e.g., the
evaluation of the method wherein the results obtained are found to be reliable, even
when performed under slightly varied conditions. It is the ability of a method to
remain unaffected when slight variations are applied. It is extremely important to
check trials of the numerical method within the same group of EEG records under
the different conditions of i) down sampling, ii) windowing, or iii) overlapping.
Moreover, it is important to check whether synchronization measures are affected
by the global analysis of different, non-consecutive chunks.
For this purpose, we selected EEG recordings of five minutes in length, from six
control individuals (without any neurological or psychiatric pathology, between 20
and 30 years old, and with no pharmacological treatment). We analyzed each EEG
under different conditions, namely:
• Down-sampling at 128 and 512 Hz, (f is for frequency).
• Windows of 1, 3 or 5 s (w).
• Overlapping at 10, 20, or 40% (o).
Overall, we had 18 combinations for frequency/windows/overlapping (f,w,o).
























; l ¼ left, r ¼ right (8)
Obviously, every structure can be described as pi f ,w, oð Þ. A robust method
should not affect the structure of EEG for the same patient, irrespective of changes
in absolute values. For each patient, we have plotted along the x-axis (coordinates
of EEG structure) the normalized band values and correlations for all of the 18
combinations (Figure 2).
From Figure 2, we can observe that different combinations cannot affect the
structure of EEG.
The effect of multiple compositions of the analyzed file on synchronicity was
assessed as follows: an EEG record of 3 min was analyzed. Then, the same record
was exported in three different chunks, and a new analysis was performed on a
recombined file with the parts randomly ordered (1,3,2/2,1,3/2,3,1/3,1,2 or 3,2,1).
We did not observed any difference in synchronization between the whole record
and a recombined one (not shown).
In summary, these results demonstrate that the method is highly robust, at least
for the limits addressed.
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5. Some examples of the utility of qEEG
It is out of the scope of this chapter to illustrate the objective and quantified
difference between the classical, de visu, analysis of EEG and qEEG. Instead, we will
provide some examples of qEEG application to real clinical problems and the
results. In these examples it will be shown that information obtained by qEEG
clearly exceeds the possibility of de visu analysis.
5.1 Differentiation between periodic patterns and seizures
Patients in the ICU usually undergo a limited clinical neurological examination
because of either structurally or functionally altered conditions of the central
Figure 2.
Structures of EEG for the 18 combinations of variables for (a) patient #1, (b) patient #2, (c) patient #3, (d) patient
#4, (e) patient#5and (f) patient#6. L= left, R = right, d =delta, t = theta, a =alpha, b =beta, and rho = correlation.
7
Necessity of Quantitative EEG for Daily Clinical Practice
DOI: http://dx.doi.org/10.5772/intechopen.94549
nervous system (CNS) or due to the effects of drugs used for sedoanalgesia [36].
Therefore, we can evaluate brain function in these conditions by EEG. However, a
dynamic evolution of injury is frequently observed in critically ill patients due to the
occurrence of epileptic seizures (ES), status epilepticus (SE), or other brain insults
[37, 38]. In this sense, cEEG allows the functional assessment of the cerebral cortex in
real time for prolonged periods. It has been proven to be an extraordinarily useful tool
for detecting electrographic seizures and non-convulsive epileptic status (NCES),
modifying treatment and assessing the functional prognosis [10, 11, 39–42].
The particularity of cEEG records of patients in the ICU comprises a high
frequency of artifacts and frequently observed rhythmic and periodic patterns,
which are easily confused with seizures. Both can be difficult to interpret not only in
a raw EEG but also with the qEEG tools currently used [43, 44]. As indicated above,
the use of multiple drugs acting on the CNS and primary and secondary injuries
profoundly affect the bioelectrical brain dynamics. Therefore, it can be quite diffi-
cult to differentiate between bursts of periodic activity (BPA) and true ES/SE. The
main problem is that EEG patterns analyzed de visu do not always exhibit the sharp
morphology of ES/SE of not-ICU patients.
According to the ILAE, an ES is a transient occurrence of signs and/or symptoms
due to abnormal excessive or synchronous neuronal activity in the cortex of the
brain [45]. Signs/symptoms are usually excluded in critically ill patients, but the
excessive activity of the cortex is mandatory for a positive identification. We have
used this pathophysiological feature for the numerical definition of ES. Therefore,
we can use this method to exclude epilepsy in those cases where α/β activity does
not change (or even decreases) during the event (see below). The limits of change
for the different bands (Table 1) can be used to distinguish PBA from ES.
From this table we can observe that the superposition is very high for δ bands
(i.e., this band is not discriminative), low for θ and Se, and practically null for α and
β bands. Therefore, the intervals for increments of normalized activity defining an
ES in these types of patients are as follows (excluding superposition and rounding):
δF ¼ 119, 166½ ; θF ¼ 173, 264½ ; θPO ¼ 168, 248½ ; θT ¼ 151, 274½ ;
αF ¼ 159, 244½ ; αPO ¼ 159, 244½ ; αT ¼ 159, 244½ ; βF ¼ 141, 374½ ; βPO ¼ 146, 262½ ;
βT ¼ 141, 374½ ; SeF ¼ 97, 110½ ; SePO ¼ 98, 107½ ; SeT ¼ 98, 104½ .
We have defined the numerical features of ES and BPA in critically ill patients
using the pathophysiological definition of epilepsy. This will facilitate its identifica-
tion in clinical practice, allowing a precocious and more adequate treatment.
5.2 Specific characterization of encephalopathy in SARS-CoV-2 patients
Neurological complications in COVID-19-infected patients have been reported.
The CNS effects reported include encephalitis, toxic encephalopathy, ageusia and
anosmia, headaches, or acute cerebrovascular disease [46–52]. The mechanisms of
CNS infection in the pathophysiology of COVID-19 are still debated, and it has been
proposed to result from direct invasion through the blood–brain barrier, a neuronal
pathway, hypoxia damage, immune-response mediated injury, or angiotensin-
converter enzyme 2 activity, among other possibilities [47, 53, 54]. Encephalopathy
refers clinically to state of impaired cognition, generally acute or subacute [55].
Descriptions de visu of EEG are based on classical analysis by visual inspection and
not on specific features [56–58].
We applied our method of qEEG to patients discharged from the ICU after
COVID-19 infection [34]. We used two control groups from patients previously
studied in our hospital: (i) patients with infectious toxic encephalopathy (ENC) and
(ii) patients after cardiorespiratory arrest (CRA), as an example of severe hypoxic
insult to the CNS.
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Visually, in COVID-19, EEG records the apparent absence of delta/theta activity
conferred a near-physiological aspect to the recordings. Despite the different visual
aspects appearing between ENC and COVID-19, the mean spectra by channel were
quite similar. Examples of typical recordings are shown in Figure 3.
We assessed the specific differences for each band in ENC, COVID-19, and CRA
patients. Subsequently, we performed one-way ANOVA (ANOVA on ranks when
normality failed) for each lobe and band, and for SSe and synchronization
(Figure 4).
The pattern of ENC and CRA was clearly different for all bands. However, the
COVID-19 group was not completely different from the ENC and CRA groups,
although it was evidently observed that the distribution is between the two extreme
groups. Nonetheless, the behavior of temporal lobes clearly differs for the ENC and
COVID-19 groups for the δ, α, and β bands. Contrary to EEG bands, SSe was higher
for the COVID-19 group and lower for the ENC group. In fact, SSe was different for
all groups at all lobes. This result may be surprising considering the kind of spectra
shown in Figure 3c, where the distribution was apparently more complex. How-
ever, the presence of α and β bands (scarcely present in the CRA group) increased
the SSe for COVID-19 patients.
Finally, although ρ was not as different between groups as SSe, a clear difference
was seen in the hemispheric synchronization and frontal lobes of ENC and COVID-
19 patients, with lower synchronization for the latter group.
In summary, we have demonstrated that qEEG can differentiate between
encephalopathy types, and we have described the numerical features of each. In this
context, we show that COVID-19 patients display EEG structures that are truly
distinguishable from those of both infectious toxic encephalopathy and encepha-
lopathies of patients who experience severe hypoxic conditions. Significantly, the
EEG pattern of COVID-19 patients was between those of the ENC and CRA groups.
Therefore, it can be speculated that hypoxia may show some participation in this
electroclinical entity. However, the EEG structures of the CRA and COVID-19
groups were different enough to consider that other factors besides hypoxia must be
responsible for the bioelectrical pattern.
It is extremely relevant to bear in mind that COVID-19 patients showed mild to
severe cognitive symptoms despite de visu quasi-normal recordings. However, the
severe numerical alterations of temporal lobes spectra, structure of SSe and
Variable State Frontal Sup (%) Parieto-occipital Sup (%) Temporal Sup (%)
Delta ES 111.8–234.0 55.4 123.8–276.8 91.3 118.4–247.6 86.1
BPA 166.3–370.4 137.1–278.7 136.3–253.9
Theta ES 158.2–264.0 14.2 166.7–247.7 1.6 139.2–230.5 19.9
BPA 92.8–173.2 84.3–168.0 93.1–157.4
Alpha ES 158.8–244.0 0 146.0–248.6 0 144.3–243.5 0
BPA 75.0–137.8 79.7–134.1 82.7–135.6
Beta ES 141.9–373.6 0 146.7–261.8 0 136.5–274.4 10.4
BPA 77.1–137.8 82.2–137-2 95.1–150.8
Entropy ES 95.5–109.5 10.7 96.2–106.7 12.4 96.1–104.8 19.5
BPA 78.9–97.0 84.3–97.5 82.3–97.8
Table 1.
Inter-percentile 25–75 intervals for bands and lobes in BPA and ES. Superposition is indicated with respect to
the ES interval [26].
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synchronization were highly different and are probably explained by symptomatol-
ogy with quasi-normal EEG traces.
5.3 Continuous EEG monitoring in ICU
Long-term EEG monitoring in the ICU (cEEG) has been one of the main devel-
oping fields of electroencephalography in recent years. There are several methods
used for EEG monitoring, and most of them share a similar philosophy: to identify
the presence of seizure/status epilepticus to make the information of monitoring
easy and fast. As stated above, we think that this reductionist approach impover-
ishes the scope of electroencephalography.
We systematically used qEEG during cEEG for the below indications:
• Monitoring the presence of ES/SE. More useful than identifying the presence of
ES, qEEG is essential to discriminate between epileptic and non-epileptic
patters, as we stated above.
Figure 3.
Examples of raw recordings: (a) encephalopathy (ENC), (b) COVID-19, and (c) cardiorespiratory arrest
(CRA). Right column shows mean spectra for channels. Red and blue lines indicate right and left hemispheres,
respectively. Y-axis units in μV2/Hz [34].
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• Titration of sedation/anti-epileptic drugs (AEDs). Identifying changes in
background from the variations in spectra or mean values of specific EEG
bands is mandatory to increase/decrease the dose of sedation. Additionally,
AEDs are adjusted with the help of qEEG, although de visu inspection of
irritative activity is mandatory.
Figure 4.
Box plots showing the comparison of EEG structures for different bands: (a) delta, (b) theta, (c) alpha, and
(d) beta, (e) Se; (f) ρ. striped black box: ECN; striped red box: COVID-19; striped blue box: CRA; black
asterisk: Difference between ENC and COVID-19; red asterisk: Difference between ENC and CRA; blue
asterisk: Difference between COVID-19 and CRA.
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• Long-term recordings in patients with alterations of consciousness without
sedo-analgesia to evaluate brain physiology. Severe encephalopathy can induce
a low-consciousness level. These recordings typically lack irritative activity,
and changes in the background are slow. However, these changes correlate
with the level of consciousness and predict the outcome. Therefore, it is
important identify changes to adjust treatment as soon as possible, especially to
avoid unnecessary therapeutic actions.
In this way, we have performed more than 250 cEEG + qEEG in the ICU in the
last five years. This is a time-consuming task (especially considering that every
cEEG takes 1.4–4.3 days (inter-percentile 25–75 range)), but the clinical utiliy is
clear because the demand increased from 1.0 0.2 cEEG/month in 2015 to 5.5 0.8
cEEG/month in 2019.
5.4 Utility in dementia
There are numerous articles in the literature showing that the initial phases of
dementia can be detected by qEEG [59–63]. We have used our numerical method in
patients with either minimum cognitive impairment (MCI) or aphasia. Obviously,
the de visu analysis of raw recordings shows only a nearly normal aspect or low-
voltage. However, numerical analysis can show very relevant facts that are not
observable by eye (Figure 5).
At this time, we are conducting a study to identify specific properties of differ-
ent pathologies (sub-types of primary aphasia, Alzheimer disease, vascular demen-
tia, etc). Although we have not yet defined different groups of features specific to
each pathology, what is clear from the above figure is that connectivity is a magni-
tude that is affected early and consistently in most cognitive alterations.
5.5 Other examples of qEEG utility
Finally, we provide two more representative examples of diagnosis highly aided
by the use of qEEG.
Case 1. A 17-year-old male patient with severe cognitive and behavioral impair-
ment, secondary to severe epileptic encephalopathy due to refractory epilepsy in
childhood after a central nervous system infection. Daily seizure frequency, with
countless seizures per day. In treatment with zonisamide (400 mg), valproic acid
(1200 mg), oxcarbazepine (1400 mg), and clobazam (10 mg) daily. Rectal diaze-
pam 10 mg if required. A video of EEG is performed in which it is observed that
during sleep, the patient exhibits several episodes of lateral head movement and
growls. De visu recordings (Figure 6a) can be described as global desynchro-
nization. However, the dynamics of the EEG bands show a decrease (practically
total) for all the bands (Figure 6b). As stated above, epilepsy is expected to be
accompanied by an increase in cortical activity (α and β bands). Therefore, this
event cannot be identified as epileptic.
Although the patient also presented true epileptic events, the number of these
was substantially lowered and AED was adjusted according to the real number of
ES. The final diagnosis for this event was a nonepileptic behavioral disorder,
secondary to severe epileptic encephalopathy.
Case 2. A 22-year-old female diagnosed with epilepsy at the age of 14 years and
with anxious-depressive illness from the age of 20 years. The applied treatment was
lamotrigine (100 mg/day) and clonazepam (0.5 mg/8 h). Seizures occurred every
2–3 days, described as the perception of black dots in the visual field, weakness, loss
of consciousness and muscle tone, loss of balance and falling to the ground. During
12
Electroencephalography - From Basic Research to Clinical Applications
telemetry, we recorded one episode of black dot perception followed by a loss of
consciousness while in bed. De visu EEG recordings showed no significant changes
(Figure 7a). However, the dynamic variation of EEG bands indicated a generalized
decrease, except for the occipital α band, which increased after the eyes closed
(Figure 7b).
The final diagnosis was psychogenic non-epileptic seizure (PNES), and the
AEDs were slowly removed.
6. Discussion
Numerous methods have been used for qEEG, although they are rarely used in
daily clinical practice. There is, therefore, a huge gap between the promising (even
spectacular) results obtained with qEEG and its practical usefulness. To the best of
the knowledge of the authors, this issue has not been systematically addressed,
although it has been said that electroencephalographers have poor trust in
mathematical models [2, 17].
The degree of mathematical complexity and abstraction is quite different among
the methods proposed. Not all of the mathematical models can be included in the
same category, and it is of extreme importance that mathematical solutions be
Figure 5.
Initial steps of dementia. (a) Example of a male with primary aphasia and (b) a female with MCI. Left
column = raw recordings of both patients; middle column = connectogram for patients; right
column = connectogram of a control volunteer of the same sex and age ( 5 years).
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robust with respect to physiological assumptions [2]. Then, some procedures require
relatively simple and involve straightforward methods as FFT [26, 34, 64–66] and
synchronicity measurements [67, 68], approaches that clinicians are familiar with.
In contrast, other numerical methods are more complex, or the mathematical
approach deviates from physiological assumptions [69–74], and this probably takes
neurophysiologists out of their comfort zone.
We have developed a robust method that is physiologically founded and easy to
use in daily clinical practice. The tools selected are neither unique nor are they
necessarily the best. Other tools (e.g., coherence) can be implemented. A careful
comparison between these methods will decide the fitted procedure for each
Figure 6.
Box plots showing a comparison of EEG structure for different bands: (a) raw recording during a complete
event during sleep. The images under the recordings correspond to the periods indicated by arrows. (b) Lobar
dynamics of EEG bands during the entire event (vertical red lines). Blue = left hemisphere; red = right
hemisphere.
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pathology. From the beginning of 2016, we have performed more than 4100
analyses and used this toolbox in most patients, even those with EEG apparently
evident. We did not use qEEG only when the record included so many artifacts
(e.g., in agitated patients) that the results would not be reliable.
The method described can be implemented to automatically differentiate
between paroxysmal events and ES during the long-term monitoring of ICU
patients. This feature is very relevant for clinicians because it can shorten the
review time, particularly during long cEEG, and can help apply adequate therapeu-
tic measures, avoiding pharmacological blind trials that only delay correct treat-
ment, increasing the inefficacy of treatment and diminishing the probability of
recuperation. Therefore, considering that “time is brain”, a fast and accurate
treatment is mandatory to increase the probability of a good outcome.
Finally, it is extremely important to keep in mind that qEEG is only a tool to help
better understand and diagnose brain pathophysiology; therefore, it should not be
thought that numerical analysis (at least as we use it today) is enough, without
evaluation by an expert, to make an automatic diagnosis. Not all brain pathologies
Figure 7.
Psychogenic non epileptic seizure (a) raw recordings (in transverse and double banana differential montages)
during the event. (b) Lobar dynamics of EEG bands during the entire event (vertical red lines). Blue = left
hemisphere; red = right hemisphere.
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are likely to benefit to the same degree from analysis. For example, the method
described in this chapter is not well fitted to detect low-frequency transitory waves
as medium/small focal epileptiform discharges, although visual inspection can
identify them very well. However, patterns that are not readily visible in de visu
analysis (e.g., asymmetries in power spectra compositions) are easily detected.
7. Conclusions
We can summarize the conclusions of this work as follows:
• qEEG is a robust and non-time-consuming method that is able to produce
numerical and objective values of several bioelectrical magnitudes with clinical
significance.
• qEEG increases and facilitates diagnoses that are otherwise exceedingly
difficult to obtain by de visu inspection. Therefore, the scope of the true
applicability of EEG is expanded far beyond epilepsy.
• We propose that qEEG use should be expanded globally for daily clinical
practice. Thus, clinical neurophysiologists should be informed of the methods
of numerical analysis procedures.
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